Skip to main content

DEUTSCHE BANK AG\

Bank

Position in VTRS — Viatris Inc

CIK 948046 FRANKFURT AM MAIN, 2M

Position in VTRS

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$87,983,060
+$34,910,147 QoQ
Shares Held
6,512,440
+52.8% QoQ
Ownership
0.559%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 40.16390170197345.ToString("F0")% Shared 0.ToString("F0")% None 59.83609829802654.ToString("F0")%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Derivatives in VTRS

reported options exposure · as of Dec 31, 2020
CallValue
$0
CallShares
0
PutValue
$7,627
PutShares
407

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

DEUTSCHE BANK AG\ holds $1,164,451,125 across 44 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (7.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 VTRS
Viatris Inc
This page
6,512,440 $87,983,060

All Filings in VTRS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $87,983,060 6,512,440
2025-12-31 $53,072,913 4,262,885
2025-09-30 $51,044,791 5,156,040
2025-06-30 $48,563,611 5,438,255
2025-03-31 $87,570,439 10,054,012
2024-12-31 $111,212,595 8,932,739
2024-09-30 $91,811,861 7,907,999
2024-06-30 $80,462,365 7,569,367
2024-03-31 $81,789,054 6,850,005
2023-12-31 $104,295,937 9,630,281
2023-09-30 $62,724,187 6,361,480
2023-06-30 $62,937,557 6,306,369
2023-03-31 $48,031,508 4,992,881
2022-12-31 $108,538,550 9,751,892
2022-09-30 $38,645,231 4,535,826
2022-06-30 $48,381,821 4,620,996
2022-03-31 $63,248,414 5,813,274
2021-12-31 $89,944,834 6,647,808
2021-09-30 $94,662,350 6,986,152
2021-06-30 $104,439,886 7,308,600
2021-03-31 $158,672,186 11,358,067
2020-12-31 $7,627 407
2020-12-31 $182,270,009 9,726,255